Grace Therapeutics (GRCE)10% owner bought ~$11K

~$11K

Approx. value · 5,340 sh @ $2.04

2.87M

Holds after · shares reported

Traded

Oct 9, 2026

Filed

Oct 13, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Aug 13, 2026Company filing · Form 8-K · ResultsReported its results
2. Sep 8, 2026Insider10% owner purchased ~$20K of GRCE shares in the open market
3. Sep 9, 2026Insider · 2 peopleInsiders: 2 purchases (~$226K)
4. Sep 21, 2026Insider10% owner purchased ~$21K of GRCE shares in the open market
5. Sep 23, 2026Insider10% owner purchased ~$11K of GRCE shares in the open market
6. Sep 29, 2026Insider10% owner purchased ~$16K of GRCE shares in the open market
7. Oct 1, 2026Insider10% owner purchased ~$79K of GRCE shares in the open market
8. Oct 2, 2026Insider10% owner purchased ~$41K of GRCE shares in the open market
9. Oct 5, 2026Insider10% owner purchased ~$3.5K of GRCE shares in the open market
10. Oct 8, 2026Insider10% owner purchased ~$4.2K of GRCE shares in the open market
11. Oct 9, 2026 · this disclosureInsider10% owner purchased ~$11K of GRCE shares in the open market

What came next

1. Oct 12, 2026Insider10% owner purchased ~$15K of GRCE shares in the open market
2. Oct 14, 2026Insider10% owner purchased ~$22K of GRCE shares in the open market
3. Oct 15, 2026Insider10% owner purchased ~$46K of GRCE shares in the open market
4. Oct 16, 2026Insider10% owner purchased ~$69K of GRCE shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Grace Therapeutics

For Grace Therapeutics, OQRO holds 15 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its GRCE page.

Other recent filings by Opaleye Management Inc., 10% owner

• SEC Form 4 at Alpha Cognition (ACOG)Oct 19, 2026
• SEC Form 4 at Alpha Cognition (ACOG)Oct 19, 2026
• SEC Form 4 at Grace Therapeutics (GRCE)Oct 17, 2026
• SEC Form 4 at Grace Therapeutics (GRCE)Oct 17, 2026
• SEC Form 4 at Grace Therapeutics (GRCE)Oct 17, 2026

The full history of Opaleye Management Inc., 10% owner is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Grace Therapeutics

• SEC Form 4Oct 17, 2026
• SEC Form 4Oct 17, 2026
• SEC Form 4Oct 17, 2026
• SEC Form 4Oct 13, 2026
• SEC Form 4Oct 13, 2026
• SEC Form 4Oct 6, 2026

Everything OQRO holds on this company is on its GRCE page.